CBD

CBD is the second most common Cannabinoid from the plant of cannabis.

CB1

CB1 is the main Cannabinoid receptor in the brain but is also found in other tissues. CB1 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently reduces cAMP upon activation. This in turn regulates many second messenger pathways. 

CBDV

CBDV is a non-psychoactive Cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.

Psychosis and Schizophrenia

Schizophrenia is a chronic mental disorder that affects around 1% of the worldwide population. It causes psychotic behaviors, social and emotional disruptions and different cognitive impairments.

The causes of the disease are still not clear but studies show that both genetic and environmental factors have an effect on it.

Epilepsy

cannabinoids have excellent therapeutic potential in epilepsy. In the brain, cannabinoids tend to keep neuronal activity wihtin acceptable boundaries.

Pain

pain is a very good target for therapeutic cannabinoids.

Prostate Cancer

Prostate cancer is the development of cancer in the prostate.

Leukemia

Leukemia cancers usually begin in the bone marrow and involves abnormal white blood cell production.

Glioblastoma

Glioblastoma is a malignant brain tumor originated in brain cells called astrocytes. Glioblastoma is one of the most promising targets for Cannabinoid therapy. Several research groups found anti-tumor properties of cannabinoids in vitro and in vivo studies.

Breast cancer

Breast cancers develop from breast tissue. cannabinoids have anti Breast Cancer properties involving inhibition of cancer growth and metastasis.